Genufood Energy Enzymes Corp.
Healthcare · Medicinal Chemicals & Botanical Products · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$432,296 | −$348,845 | −$363,637 | −$309,907 | −$303,509 | −$282,176 |
| Net income | −$627,702 | −$352,668 | −$1.4M | −$311,109 | −$303,576 | −$282,174 |
| Total assets | $201,562 | $150,893 | $385,044 | $18,092 | $121,707 | $167,976 |
| Total liabilities | — | — | — | — | — | — |
| Equity | $53,720 | −$83,349 | $253,472 | −$352,943 | −$232,344 | −$109,365 |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 299.7M | 299.7M | 211.1M | 9.12B | 91.2M | 6.92B |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- —
- Net margin
- —
- Return on equity
- −1168.5%
- Return on assets
- −311.4%
- Return on capital (ROCE)
- −503.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.00
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Accruals / assets
- −160.1%clean
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 1 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 15, 2024
- NT 10-Kmissed a reporting deadline ↗Dec 29, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2023
- NT 10-Kmissed a reporting deadline ↗Dec 30, 2022
- NT 10-Qmissed a reporting deadline ↗Feb 9, 2022
- NT 10-Kmissed a reporting deadline ↗Dec 29, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lai Wen PiaoDirector | Jun 15, 2021 | Buy | 8.0M | $0.01 |
| Tsai Kuang MingDirector | Jul 15, 2021 | Buy | 1.0M | $0.01 |
| Wang Shao-ChengOfficer — CFO, Treasurer and Secretary | Jun 15, 2021 | Buy | 4.0M | $0.01 |
| Tsai Kuang MingDirector | Mar 31, 2021 | J | 1.5M | $0.01 |
| Wang Shao-ChengOfficer — CFO, Treasurer and Secretary | Mar 31, 2021 | J | 201,889 | $0.05 |
| Lin Jui PinOfficer — President and CEO | Mar 31, 2021 | J | 420,000 | $0.05 |
| Wang Shao-ChengOfficer — CFO, Treasurer and Secretary | Dec 15, 2020 | Buy | 6.0M | $0.01 |
| Lin Jui PinOfficer — President and CEO | Dec 15, 2020 | Buy | 30.0M | $0.01 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer change · Amended charter or bylawsJul 27, 2023
- Prior financials not reliable (restatement)Jun 1, 2023
- Entered a material agreement · Unregistered equity saleMar 2, 2023
- Other material eventNov 4, 2022
- Other material eventAug 16, 2022
- Director / officer change · Other material eventAug 4, 2022
- Director / officer changeJul 29, 2022
- Changed auditorFeb 28, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QQUARTERLY REPORTFeb 20, 2024
- NT 10-QNOTIFICATION OF LATE FILINGFeb 15, 2024
- 10-KANNUAL REPORTJan 12, 2024
- NT 10-KNOTIFICATION OF LATE FILINGDec 29, 2023
- 10-Q/AAMENDMENT NO. 1 TO FORM 10-QOct 11, 2023
- 10-K/AAMENDMENT NO. 1 TO FORM 10-KAug 23, 2023
- 10-QQUARTERLY REPORTAug 14, 2023
- 8-KCURRENT REPORTJul 27, 2023
- 10-QQUARTERLY REPORTJun 2, 2023
- 8-KCURRENT REPORTJun 1, 2023
- NT 10-QNOTIFICATION OF LATE FILINGMay 16, 2023
- 8-KCURRENT REPORTMar 2, 2023
- 10-QQUARTERLY REPORTFeb 14, 2023
- 10-KANNUAL REPORTJan 17, 2023
- NT 10-KNOTIFICATION OF LATE FILINGDec 30, 2022